Browsing Tag
Hemogenyx Pharmaceuticals
5 posts
Hemogenyx Pharmaceuticals stock jumps after third patient in CAR-T AML trial shows safety and early efficacy
Hemogenyx Pharmaceuticals (LSE: HEMO) stock jumps 24% after third patient treated in CAR-T AML trial shows safety and early efficacy.
Hemogenyx Pharmaceuticals launches Phase I AML trial for HG-CT-1 CAR-T therapy
Hemogenyx Pharmaceuticals plc (LSE: HEMO), a leading biopharmaceutical company, has taken a significant step forward in the fight…
Hemogenyx Pharmaceuticals innovates brain cancer treatment with CBR delivery
Hemogenyx Pharmaceuticals plc (LSE: HEMO), a clinical-stage biopharmaceutical group, has made a significant advancement in medical science by…
Hemogenyx Pharmaceuticals innovates with intranasal mRNA delivery for airborne viral infections
Hemogenyx Pharmaceuticals plc (LSE: HEMO), a clinical-stage biopharmaceutical group, has made a significant stride in the realm of…
Hemogenyx Pharmaceuticals receives FDA nod for HEMO-CAR-T AML treatment study
Hemogenyx Pharmaceuticals plc, a London-based biopharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA)…